Annual Cash & Cash Equivalents
$1.42 M
-$606.20 K-29.86%
31 December 2023
Summary:
China Pharma Holdings annual cash & cash equivalents is currently $1.42 million, with the most recent change of -$606.20 thousand (-29.86%) on 31 December 2023. During the last 3 years, it has risen by +$466.10 thousand (+48.67%). CPHI annual cash & cash equivalents is now -79.45% below its all-time high of $6.93 million, reached on 31 December 2008.CPHI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$718.70 K
-$20.60 K-2.79%
30 September 2024
Summary:
China Pharma Holdings quarterly cash and cash equivalents is currently $718.70 thousand, with the most recent change of -$20.60 thousand (-2.79%) on 30 September 2024. Over the past year, it has dropped by -$651.20 thousand (-47.54%). CPHI quarterly cash and cash equivalents is now -90.10% below its all-time high of $7.26 million, reached on 31 March 2016.CPHI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.9% | -47.5% |
| 3 y3 years | +48.7% | +56.6% |
| 5 y5 years | +20.0% | -5.6% |
CPHI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.7% | +48.7% | -85.2% | +56.6% |
| 5 y | 5 years | -70.7% | +48.7% | -85.2% | +392.6% |
| alltime | all time | -79.5% | >+9999.0% | -90.1% | >+9999.0% |
China Pharma Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $718.70 K(-2.8%) |
| June 2024 | - | $739.30 K(-11.9%) |
| Mar 2024 | - | $838.90 K(-41.1%) |
| Dec 2023 | $1.42 M(-29.9%) | $1.42 M(+3.9%) |
| Sept 2023 | - | $1.37 M(+51.9%) |
| June 2023 | - | $901.90 K(-22.7%) |
| Mar 2023 | - | $1.17 M(-42.5%) |
| Dec 2022 | $2.03 M(-58.2%) | $2.03 M(-2.7%) |
| Sept 2022 | - | $2.09 M(-7.1%) |
| June 2022 | - | $2.25 M(-39.6%) |
| Mar 2022 | - | $3.71 M(-23.5%) |
| Dec 2021 | $4.86 M(+407.4%) | $4.86 M(+959.1%) |
| Sept 2021 | - | $458.80 K(-73.9%) |
| June 2021 | - | $1.75 M(+228.3%) |
| Mar 2021 | - | $534.50 K(-44.2%) |
| Dec 2020 | $957.70 K(-10.9%) | $957.70 K(+176.3%) |
| Sept 2020 | - | $346.60 K(-80.9%) |
| June 2020 | - | $1.81 M(+1143.0%) |
| Mar 2020 | - | $145.90 K(-86.4%) |
| Dec 2019 | $1.07 M(-9.4%) | $1.07 M(+41.2%) |
| Sept 2019 | - | $761.60 K(-54.0%) |
| June 2019 | - | $1.66 M(+72.3%) |
| Mar 2019 | - | $961.30 K(-19.0%) |
| Dec 2018 | $1.19 M(-41.6%) | $1.19 M(+77.7%) |
| Sept 2018 | - | $667.60 K(-65.5%) |
| June 2018 | - | $1.94 M(-21.6%) |
| Mar 2018 | - | $2.47 M(+21.6%) |
| Dec 2017 | $2.03 M(-23.8%) | $2.03 M(+80.6%) |
| Sept 2017 | - | $1.12 M(-35.6%) |
| June 2017 | - | $1.75 M(-30.8%) |
| Mar 2017 | - | $2.52 M(-5.3%) |
| Dec 2016 | $2.67 M(-57.3%) | $2.67 M(-27.0%) |
| Sept 2016 | - | $3.65 M(-41.9%) |
| June 2016 | - | $6.29 M(-13.4%) |
| Mar 2016 | - | $7.26 M(+16.2%) |
| Dec 2015 | $6.25 M(+18.0%) | $6.25 M(+8.8%) |
| Sept 2015 | - | $5.74 M(+26.2%) |
| June 2015 | - | $4.55 M(-13.7%) |
| Mar 2015 | - | $5.27 M(-0.5%) |
| Dec 2014 | $5.30 M(-11.6%) | $5.30 M(+24.1%) |
| Sept 2014 | - | $4.27 M(-3.5%) |
| June 2014 | - | $4.43 M(-16.4%) |
| Mar 2014 | - | $5.29 M(-11.7%) |
| Dec 2013 | $5.99 M | $5.99 M(+33.0%) |
| Sept 2013 | - | $4.51 M(+78.5%) |
| June 2013 | - | $2.52 M(-46.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $4.75 M(+17.9%) |
| Dec 2012 | $4.03 M(-0.5%) | $4.03 M(-25.7%) |
| Sept 2012 | - | $5.43 M(+1.8%) |
| June 2012 | - | $5.33 M(+44.7%) |
| Mar 2012 | - | $3.69 M(-9.0%) |
| Dec 2011 | $4.05 M(+9.7%) | $4.05 M(-18.7%) |
| Sept 2011 | - | $4.98 M(+1.2%) |
| June 2011 | - | $4.93 M(+15.3%) |
| Mar 2011 | - | $4.27 M(+15.7%) |
| Dec 2010 | $3.69 M(+1.6%) | $3.69 M(-19.1%) |
| Sept 2010 | - | $4.56 M(+0.7%) |
| June 2010 | - | $4.53 M(-5.4%) |
| Mar 2010 | - | $4.78 M(+31.6%) |
| Dec 2009 | $3.63 M(-47.5%) | $3.63 M(-5.5%) |
| Sept 2009 | - | $3.84 M(+5.5%) |
| June 2009 | - | $3.64 M(-29.3%) |
| Mar 2009 | - | $5.15 M(-25.6%) |
| Dec 2008 | $6.93 M(+278.5%) | $6.93 M(+18.6%) |
| Sept 2008 | - | $5.84 M(-17.0%) |
| June 2008 | - | $7.04 M(+931.8%) |
| Mar 2008 | - | $682.00 K(-62.7%) |
| Dec 2007 | $1.83 M(+178.8%) | $1.83 M(+6.7%) |
| Sept 2007 | - | $1.72 M(-29.6%) |
| June 2007 | - | $2.44 M(-17.4%) |
| Mar 2007 | - | $2.95 M(+349.5%) |
| Dec 2006 | $656.40 K(+42.3%) | $656.40 K(+239.4%) |
| Sept 2006 | - | $193.40 K(-0.9%) |
| June 2006 | - | $195.20 K(+160.6%) |
| Mar 2006 | - | $74.90 K(-97.9%) |
| Dec 2005 | $461.20 K(>+9900.0%) | - |
| Sept 2005 | - | $3.56 M(>+9900.0%) |
| Mar 2005 | - | $100.00(0.0%) |
| Dec 2004 | - | $100.00(0.0%) |
| Sept 2004 | - | $100.00(0.0%) |
| June 2004 | $100.00(-94.4%) | $100.00(0.0%) |
| Mar 2004 | - | $100.00(0.0%) |
| Dec 2003 | - | $100.00(-75.0%) |
| Sept 2003 | - | $400.00(-77.8%) |
| June 2003 | $1800.00(+38.5%) | $1800.00(+800.0%) |
| Mar 2003 | - | $200.00(-99.2%) |
| Dec 2002 | - | $25.90 K(-56.3%) |
| Sept 2002 | - | $59.20 K(+4453.8%) |
| June 2002 | $1300.00 | $1300.00(-93.9%) |
| Mar 2002 | - | $21.40 K(+1428.6%) |
| Dec 2001 | - | $1400.00(+180.0%) |
| Sept 2001 | - | $500.00 |
FAQ
- What is China Pharma Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for China Pharma Holdings?
- What is China Pharma Holdings annual cash & cash equivalents year-on-year change?
- What is China Pharma Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for China Pharma Holdings?
- What is China Pharma Holdings quarterly cash and cash equivalents year-on-year change?
What is China Pharma Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of CPHI is $1.42 M
What is the all time high annual cash & cash equivalents for China Pharma Holdings?
China Pharma Holdings all-time high annual cash & cash equivalents is $6.93 M
What is China Pharma Holdings annual cash & cash equivalents year-on-year change?
Over the past year, CPHI annual cash & cash equivalents has changed by -$606.20 K (-29.86%)
What is China Pharma Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CPHI is $718.70 K
What is the all time high quarterly cash and cash equivalents for China Pharma Holdings?
China Pharma Holdings all-time high quarterly cash and cash equivalents is $7.26 M
What is China Pharma Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, CPHI quarterly cash and cash equivalents has changed by -$651.20 K (-47.54%)